Latest stories on OPRX
OptimizeRx Sets Third Quarter 2026 Conference Call for November 11, 2026 at 4:30 p.m. ET
Business Insider50 · neutralgeneral
Chuck Royce Adds OptimizeRx Corp (OPRX) -- Shares Look 19% Undervalued on GF Value
GuruFocus64 · neutralanalyst
OptimizeRx announces new partnership with PulsePoint
The Fly61 · neutralproduct/pr
OptimizeRx and PulsePoint Partner to Connect HCP Media Across the Funnel
Business Insider61 · neutralproduct/pr
Citizens reiterates OptimizeRx stock rating citing digital spend expansion
Investing.com Analyst Ratings56 · neutralanalyst
OptimizeRx Partners With The Trade Desk To Widen Its Healthcare Ad Network
Stocktwits News66 · bullishproduct/pr
OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath
GlobeNewswire63 · neutralproduct/pr
OptimizeRx: Gross Margin Gains And Improved Long-Term Outlook
Seeking Alpha67 · bullishanalyst
OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence
StockTitan63 · neutralproduct/pr
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
GlobeNewswire55 · neutralgeneral
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
Business Insider55 · neutralgeneral
OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor
StockTitan56 · neutralgeneral
OptimizeRx (OPRX) Q2 2026 Earnings Call Transcript
The Motley Fool56 · neutralearnings
OptimizeRx backs FY26 revenue view $95M-$100M, consensus $97.41M
The Fly56 · neutralearnings
OptimizeRx reports Q2 EPS 16c, consensus 11c
The Fly68 · bullishearnings
OptimizeRx names Andy D’Silva CFO, Heather Favazza chief accounting officer
The Fly50 · neutralgeneral
OptimizeRx price target lowered to $12 from $14 at Stifel
The Fly34 · bearishanalyst
OptimizeRx price target raised to $11 from $9 at Citizens
The Fly63 · neutralanalyst
Citizens raises OptimizeRx stock price target on macro stability
Investing.com Analyst Ratings61 · neutralanalyst
Stifel cuts OptimizeRx stock price target on revenue headwinds
Investing.com Analyst Ratings38 · neutralanalyst
OptimizeRx reiterates $95M-$100M 2026 revenue outlook amid CFO transition
Seeking Alpha63 · neutralearnings
OptimizeRx Corporation (OPRX) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
OptimizeRx Names D'Silva Chief Financial Officer
MarketWatch55 · neutralgeneral
OptimizeRx names Andy D’Silva CFO
Seeking Alpha55 · neutralgeneral
OptimizeRx Reaffirms 2026 Outlook Amid Revenue Decline
TipRanks53 · neutralgeneral